Communication signals between cardiac fibroblasts and cardiac myocytes

Journal of Cardiovascular Pharmacology

Volumn 57, Issue 5, 2011, Pages 513-521

  Ottaviano, Filomena G ^a   Yee, Karen O ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

connexin; cytokines; growth factors; heart; integrin; matrix; VEGF receptor 1; VEGF B

Indexed keywords

CADHERIN; CYTOKINE; GAP JUNCTION PROTEIN; GROWTH FACTOR; INTEGRIN; VASCULOTROPIN B; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; CARDIAC FIBROBLAST; CELL COMMUNICATION; EXTRACELLULAR MATRIX; FIBROBLAST; HEART DISEASE; HEART FUNCTION; HEART MUSCLE CELL; HUMAN; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL COMMUNICATION; CYTOKINES; FIBROBLASTS; HEART; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MYOCYTES, CARDIAC; PARACRINE COMMUNICATION;

EID: 79957720871     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e31821209ee     Document Type: Review

References (96)

1. Nag AC. Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution. Cytobios. 1980;28:41-61 (Pubitemid 11219342)
2. Zak R. Development and proliferative capacity of cardiac muscle cells. Circ Res. 1974;35(suppl II):17-26
3. Baudino TA, Carver W, Giles W, et al. Cardiac fibroblasts: friend or foe? Am J Physiol Heart Circ Physiol. 2006;291:H1015-H1026
4. Camelliti P, Borg TK, Kohl P. Structural and functional characterisation of cardiac fibroblasts. Cardiovasc Res. 2005;65:40-51 (Pubitemid 40038477)
5. Camelliti P, McCulloch AD, Kohl P. Microstructured cocultures of cardiac myocytes and fibroblasts: a two-dimensional in vitro model of cardiac tissue. Microsc Microanal. 2005;11:249-259 (Pubitemid 40870194)
6. Souders CA, Bowers SL, Baudino TA. Cardiac fibroblast: the renaissance cell. Circ Res. 2009;105:1164-1176
7. Bowers SL, Borg TK, Baudino TA. The dynamics of fibroblast-myocyte- capillary interactions in the heart. Ann N Y Acad Sci. 2010;1188:143-152
8. Schneider M, Kostin S, Strom CC, et al. S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes. Cardiovasc Res. 2007;75:40-50 (Pubitemid 46881062)
9. Xie R, Schlumbrecht MP, Shipley GL, et al. S100A4 mediates endometrial cancer invasion and is a target of TGF-beta1 signaling. Lab Invest. 2009;89:937-947
10. Strutz F, Okada H, Lo CW, et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol. 1995;130:393-405
11. Eghbali M, Tomek R, Woods C, et al. Cardiac fibroblasts are predisposed to convert into myocyte phenotype: specific effect of transforming growth factor beta. Proc Natl Acad Sci U S A. 1991;88:795-799 (Pubitemid 21916110)
12. Sun Y, Weber KT. Infarct scar: a dynamic tissue. Cardiovasc Res. 2000; 46:250-256 (Pubitemid 30204596)
13. Yutzey KE, Bader D. Diversification of cardiomyogenic cell lineages during early heart development. Circ Res. 1995;77:216-219
14. Melnik N, Yutzey KE, Gannon M, et al. Commitment, differentiation, and diversification of avian cardiac progenitor cells. Ann N Y Acad Sci. 1995; 752:1-8
15. Smith TK, Bader DM. Signals from both sides: control of cardiac development by the endocardium and epicardium. Semin Cell Dev Biol. 2007;18:84-89 (Pubitemid 46350740)
16. Markwald RR, Fitzharris TP, Manasek FJ. Structural development of endocardial cushions. Am J Anat. 1977;148:85-119 (Pubitemid 8034351)
17. Viragh S, Gittenberger-de Groot AC, Poelmann RE, et al. Early development of quail heart epicardium and associated vascular and glandular structures. Anat Embryol (Berl). 1993;188:381-393 (Pubitemid 23305159)
18. Viragh S, Challice CE. The origin of the epicardium and the embryonic myocardial circulation in the mouse. Anat Rec. 1981;201:157-168 (Pubitemid 11004831)
19. Mikawa T, Gourdie RG. Pericardial mesoderm generates a population of coronary smooth muscle cells migrating into the heart along with ingrowth of the epicardial organ. Dev Biol. 1996;174:221-232 (Pubitemid 26132683)
20. Ieda M, Fu JD, Delgado-Olguin P, et al. Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell. 2010; 142:375-386
21. Kakkar R, Lee RT. Intramyocardial fibroblast myocyte communication. Circ Res. 2010;106:47-57
22. Nian M, Lee P, Khaper N, et al. Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res. 2004;94:1543-1553 (Pubitemid 38856961)
23. Siwik DA, Chang DL, Colucci WS. Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro. Circ Res. 2000;86:1259-1265 (Pubitemid 30436667)
24. Xie Z, Singh M, Singh K. Differential regulation of matrix metalloproteinase- 2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1 beta. J Biol Chem. 2004;279: 39513-39519 (Pubitemid 39258218)
25. Banerjee I, Fuseler JW, Intwala AR, et al. IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart. Am J Physiol Heart Circ Physiol. 2009;296:H1694-H1704
26. Coles B, Fielding CA, Rose-John S, et al. Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo. Am J Pathol. 2007;171:315-325 (Pubitemid 47339248)
27. Tsuruda T, Costello-Boerrigter LC, Burnett JC Jr. Matrix metalloproteinases: pathways of induction by bioactive molecules. Heart Fail Rev. 2004;9:53-61 (Pubitemid 38196077)
28. Torre-Amione G, Kapadia S, Lee J, et al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704-711
29. Torre-Amione G, Kapadia S, Benedict C, et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol. 1996;27:1201-1206 (Pubitemid 26117714)
30. Heimer R, Bashey RI, Kyle J, et al. TGF-beta modulates the synthesis of proteoglycans by myocardial fibroblasts in culture. J Mol Cell Cardiol. 1995;27:2191-2198
31. Villarreal FJ, Lee AA, Dillmann WH, et al. Adenovirus-mediated overexpression of human transforming growth factor-beta 1 in rat cardiac fibroblasts, myocytes and smooth muscle cells. J Mol Cell Cardiol. 1996; 28:735-742
32. Leask A. TGFbeta, cardiac fibroblasts, and the fibrotic response. Cardiovasc Res. 2007;74:207-212 (Pubitemid 46533834)
33. Schultz Jel J, Witt SA, Glascock BJ, et al. TGF-beta1 mediates the hypertrophic cardiomyocyte growth induced by angiotensin II. J Clin Invest. 2002;109:787-796 (Pubitemid 34263155)
34. LaFramboise WA, Scalise D, Stoodley P, et al. Cardiac fibroblasts influence cardiomyocyte phenotype in vitro. Am J Physiol Cell Physiol. 2007;292:C1799-C1808 (Pubitemid 47080551)
35. Corda S, Samuel JL, Rappaport L. Extracellular matrix and growth factors during heart growth. Heart Fail Rev. 2000;5:119-130
36. Banerjee I, Yekkala K, Borg TK, et al. Dynamic interactions between myocytes, fibroblasts, and extracellular matrix. Ann N Y Acad Sci. 2006; 1080:76-84 (Pubitemid 44955414)
37. Pauschinger M, Knopf D, Petschauer S, et al. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation. 1999;99:2750-2756 (Pubitemid 29250020)
38. Bishop JE, Greenbaum R, Gibson DG, et al. Enhanced deposition of predominantly type I collagen in myocardial disease. J Mol Cell Cardiol. 1990;22:1157-1165 (Pubitemid 20378828)
39. Carver W, Nagpal ML, Nachtigal M, et al. Collagen expression in mechanically stimulated cardiac fibroblasts. Circ Res. 1991;69:116-122
40. Laser M, Willey CD, Jiang W, et al. Integrin activation and focal complex formation in cardiac hypertrophy. J Biol Chem. 2000;275:35624-35630
41. Ieda M, Tsuchihashi T, Ivey KN, et al. Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling. Dev Cell. 2009; 16:233-244
42. Goodenough DA, Goliger JA, Paul DL. Connexins, connexons, and intercellular communication. Annu Rev Biochem. 1996;65:475-502 (Pubitemid 26250617)
43. Musil LS, Goodenough DA. Gap junctional intercellular communication and the regulation of connexin expression and function. Curr Opin Cell Biol. 1990;2:875-880
44. Thomas SA, Schuessler RB, Berul CI, et al. Disparate effects of deficient expression of connexin43 on atrial and ventricular conduction: evidence for chamber-specific molecular determinants of conduction. Circulation. 1998;97:686-691 (Pubitemid 28090963)
45. Gutstein DE, Morley GE, Tamaddon H, et al. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res. 2001;88:333-339 (Pubitemid 32173758)
46. Beauchamp P, Choby C, Desplantez T, et al. Electrical propagation in synthetic ventricular myocyte strands from germline connexin43 knockout mice. Circ Res. 2004;95:170-178 (Pubitemid 38988683)
47. Darrow BJ, Laing JG, Lampe PD, et al. Expression of multiple connexins in cultured neonatal rat ventricular myocytes. Circ Res. 1995;76:381-387
48. Duffy HS, Fort AG, Spray DC. Cardiac connexins: genes to nexus. Adv Cardiol. 2006;42:1-17 (Pubitemid 43805854)
49. Ahmad S, Diez JA, George CH, et al. Synthesis and assembly of connexins in vitro into homomeric and heteromeric functional gap junction hemichannels. Biochem J. 1999;339:247-253 (Pubitemid 29209954)
50. Ahmad S, Iriondo JD, Evans WH. Cell-free synthesis and assembly of connexins into functional gap junction hemichannels. Biochem Soc Trans. 1998;26:S304 (Pubitemid 128723767)
51. Zhang JT, Chen M, Foote CI, et al. Membrane integration of in vitro translated gap junctional proteins: co- and post-translational mechanisms. Mol Biol Cell. 1996;7:471-482 (Pubitemid 26089660)
52. Thomas T, Jordan K, Simek J et al. Mechanisms of Cx43 and Cx26 transport to the plasma membrane and gap junction regeneration. J Cell Sci. 2005;118:4451-4462 (Pubitemid 41556343)
53. Shaw RM, Fay AJ, Puthenveedu MA, et al. Microtubule plus-end-tracking proteins target gap junctions directly from the cell interior to adherens junctions. Cell. 2007;128:547-560 (Pubitemid 46198893)
54. Husoy T, Cruciani V, Knutsen HK, et al. Cells heterozygous for the ApcMin mutation have decreased gap junctional intercellular communication and connexin43 level, and reduced microtubule polymerization. Carcinogenesis. 2003;24:643-650 (Pubitemid 36592398)
55. Rook MB, Jongsma HJ, de Jonge B. Single channel currents of homo- and heterologous gap junctions between cardiac fibroblasts and myocytes. P2flugers Arch. 1989;414:95-98 (Pubitemid 19140449)
56. Camelliti P, Devlin GP, Matthews KG, et al. Spatially and temporally distinct expression of fibroblast connexins after sheep ventricular infarction. Cardiovasc Res. 2004;62:415-425 (Pubitemid 38496554)
57. Chilton L, Giles WR, Smith GL. Evidence of intercellular coupling between co-cultured adult rabbit ventricular myocytes and myofibroblasts. J Physiol. 2007;583:225-236 (Pubitemid 47244255)
58. Goshima K, Tonomura Y. Synchronized beating of embryonic mouse myocardial cells mediated by FL cells in monolayer culture. Exp Cell Res. 1969;56:387-392
59. Goshima K. Formation of nexuses and electrotonic transmission between myocardial and FL cells inmonolayer culture. Exp Cell Res. 1970;63:124-130
60. Vasquez C, Mohandas P, Louie KL, et al. Enhanced fibroblast-myocyte interactions in response to cardiac injury. Circ Res. 2010;107:1011-1020
61. Pimentel RC, Yamada KA, Kleber AG, et al. Autocrine regulation of myocyte Cx43 expression by VEGF. Circ Res. 2002;90:671-677 (Pubitemid 34640885)
62. Giordano FJ, Gerber HP, Williams SP, et al. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A. 2001;98:5780-5785 (Pubitemid 32435719)
63. Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439-442 (Pubitemid 26102720)
64. Nagy JA, Benjamin L, Zeng H, et al. Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis. 2008;11:109-119
65. Zhang F, Tang Z, Hou X, et al. VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis. Proc Natl Acad Sci U S A. 2009;106: 6152-6157
66. Tammela T, Enholm B, Alitalo K, et al. The biology of vascular endothelial growth factors. Cardiovasc Res. 2005;65:550-563 (Pubitemid 40138976)
67. Olofsson B, Pajusola K, Kaipainen A, et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci U S A. 1996;93:2576-2581 (Pubitemid 26104389)
68. Ng YS, Rohan R, Sunday ME, et al. Differential expression of VEGF isoforms in mouse during development and in the adult. Dev Dyn. 2001; 220:112-121 (Pubitemid 32107812)
69. Olofsson B, Pajusola K, Euler G, et al. Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J Biol Chem. 1996;271: 19310-19317 (Pubitemid 26271600)
70. Li X, Eriksson U. Novel VEGF family members: VEGF-B, VEGF-C and VEGF-D. Int J Biochem Cell Biol. 2001;33:421-426 (Pubitemid 32324007)
71. Silvestre JS, Tamarat R, Ebrahimian TG, et al. Vascular endothelial growth factor-B promotes in vivo angiogenesis. Circ Res. 2003;93: 114-123 (Pubitemid 36919698)
72. Mould AW, Greco SA, Cahill MM, et al. Transgenic overexpression of vascular endothelial growth factor-B isoforms by endothelial cells potentiates postnatal vessel growth in vivo and in vitro. Circ Res. 2005;97:e60-e70
73. Li X, Tjwa M, Van Hove I, et al. Reevaluation of the role of VEGF-B suggests a restricted role in the revascularization of the ischemic myocardium. Arterioscler Thromb Vasc Biol. 2008;28:1614-1620
74. Karpanen T, Bry M, Ollila HM, et al. Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy. Circ Res. 2008; 103:1018-1026
75. Hagberg CE, Falkevall A, Wang X, et al. Vascular endothelial growth factor B controls endothelial fatty acid uptake. Nature. 2010;464: 917-921
76. Bry M, Kivela R, Holopainen T, et al. Vascular endothelial growth factor-B acts as a coronary growth factor in transgenic rats without inducing angiogenesis, vascular leak, or inflammation. Circulation. 2010;122: 1725-1733
77. Bellomo D, Headrick JP, Silins GU, et al. Mice lacking the vascular endothelial growth factor-B gene (VEGFB) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res. 2000;86:E29-E35
78. Aase K, von Euler G, Li X, et al. Vascular endothelial growth factor-B deficient mice display an atrial conduction defect. Circulation. 2001;104: 358-364 (Pubitemid 32666961)
79. Hiratsuka S, Minowa O, Kuno J, et al. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci U S A. 1998;95:9349-9354 (Pubitemid 28506234)
80. Kearney JB, Kappas NC, Ellerstrom C, et al. The VEGF receptor flt-1 (VEGFR-1) is a positive modulator of vascular sprout formation and branching morphogenesis. Blood. 2004;103:4527-4535 (Pubitemid 38745980)
81. Nishi J, Minamino T, Miyauchi H, et al. Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt. Circ Res. 2008;103:261-268
82. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature. 1995;376: 62-66
83. Fong GH, Zhang L, Bryce DM, et al. Increased hemangioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development. 1999;126:3015-3025 (Pubitemid 29355693)
84. Haspel HC, Scicli GM, McMahon G, et al. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis. Microvasc Res. 2002;63:304-315 (Pubitemid 34971626)
85. Carmeliet P, Moons L, Luttun A, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med. 2001;7:575-583 (Pubitemid 32448325)
86. Huang K, Andersson C, Roomans GM, et al. Signaling properties of VEGF receptor- and -2 homo- and heterodimers. Int J Biochem Cell Biol. 2001;33:315-324 (Pubitemid 32324000)
87. Autiero M, Waltenberger J, Communi D, et al. Role of PlGF in the intra - and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med. 2003;9:936-943 (Pubitemid 36889938)
88. Zhou Y, Bourcy K, Kang YJ. Copper-induced regression of cardiomyocyte hypertrophy is associated with enhanced vascular endothelial growth factor receptor-1 signalling pathway. Cardiovasc Res. 2009;84:54-63
89. Kaza E, Ablasser K, Poutias D, et al. Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium. Cardiovasc Res. 2011;89:410-418
90. Takimoto E, Champion HC, Belardi D, et al. cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3- dependent mechanism. Circ Res. 2005;96:100-109 (Pubitemid 40095759)
91. Zentilin L, Puligadda U, Lionetti V, et al. Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction. Faseb J. 2010;24:1467-1478
92. Pepe M, Mamdani M, Zentilin L, et al. Intramyocardial VEGF-B167 gene delivery delays the progression towards congestive failure in dogs with pacing-induced dilated cardiomyopathy. Circ Res. 2010;106: 1893-1903
93. Goncalves GA, Vassallo PF, dos Santos L, et al. Intramyocardial transplantation of fibroblasts expressing vascular endothelial growth factor attenuates cardiac dysfunction. Gene Ther. 2010;17:305-314
94. Geisterfer-Lowrance AA, Christe M, Conner DA, et al. A mouse model of familial hypertrophic cardiomyopathy. Science. 1996;272:731-734 (Pubitemid 26000280)
95. Schmitt JP, Debold EP, Ahmad F, et al. Cardiac myosin missense mutations cause dilated cardiomyopathy in mouse models and depress molecular motor function. Proc Natl Acad Sci U S A. 2006;103:14525-14530 (Pubitemid 44484783)
96. Young M, Fullerton M, Dilley R, et al. Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest. 1994;93:2578-2583 (Pubitemid 24177174)